Skip to content
GLP-1 Scorecard
Menu

Head-to-head · WeighScore

Ark Health vs NowPatient

By GLP-1 ScorecardUpdated

Ark Health
Site position #458

Lower grade

NowPatient
Site position #243

Higher grade

Score comparison

NowPatient has the higher recorded score — 65.5/100 to 56.8/100.

NowPatient grades higher on WeighScore, our editorial score across cost value, dose & formulation, clinical oversight, labs & monitoring, fulfillment and contract terms. NowPatient is a US-UK telehealth platform offering brand-name GLP-1 weight management access including Mounjaro, Wegovy (injection and oral tablet), and Saxenda.

We may earn a commission through these links, at no extra cost to you. Commercial relationships affect placement, but never the WeighScore or our editorial findings. See our disclosure.

Factor by factor

These are recorded editorial marks, not a measure of clinical outcomes. Current prices and terms may differ from those used in the marks. See the methodology.

Cost valueNowPatient +1
34
35
Dose & formulationNowPatient +5
88
93
Clinical oversightNowPatient +27
59
86
Labs & monitoringNowPatient +2
52
54
FulfillmentNowPatient +14
56
70
Contract termsEven
55
55
Ark Health · top barNowPatient · bottom bar

The numbers

Swipe or scroll to compare both providers.

MetricArk HealthNowPatient
WeighScore56.8/10065.5/100
GradeCC
Site position#458#243
Semaglutide$1,399/mo (brand Ozempic)$1,349/mo (brand Wegovy)
Tirzepatide$1,499/mo (brand Mounjaro)$1,069/mo (brand Mounjaro, promotional rate)
CoverageCoverage not publishedCoverage not published
Brand-name accessYesYes
Oral / sublingualYesYes
Ark Health

Site position #458 · C

Strengths

  • Broadest menu in the directory — compounded sema/tirz injection, oral sema, brand Ozempic and Mounjaro, Sermorelin, MIC/B12
  • Consistent pricing at all dosages — flat rate, no escalation as you titrate up
  • Compounded oral semaglutide at $125/mo is competitive for a niche most providers don't offer
  • Free expedited shipping included
  • Phone support published (uncommon among DTC platforms)

What to consider

  • States served not listed — can't confirm coverage in your state without contacting support
  • LegitScript status not disclosed — no badge or verifiable ID
  • FDA compounded-medication disclaimer not displayed
  • Medical director / clinical lead not named — only generic 'certified healthcare providers'
  • Pharmacy partner not named; 503A vs 503B unspecified
NowPatient

Site position #243 · C

Strengths

  • Free telehealth consultation — you only pay for the medication
  • Brand-name Mounjaro, Wegovy injection, Wegovy oral tablet, and Saxenda all available
  • One of the few platforms offering Wegovy in both injection and oral pill form
  • No compounded options — every drug is FDA-approved brand-name

What to consider

  • Cash-pay pricing tracks full brand list price (~$1,000–$1,350/mo)
  • No compounded semaglutide or tirzepatide (usually the cheaper route)
  • State availability determined during intake, not shown upfront
  • Does not offer Foundayo (orforglipron)

Featured provider

CoreAge Rx

CoreAge Rx scores 89.5/100 (B+). Advertises pricing across doses with no membership fee, but starting-price displays and FAQ payment/refund promises need to be reconciled with the selected plan and refund policy.

Commercial relationships affect this placement. The score comparison above is separate.

Pricing/verification reflect each provider's public disclosures at last grading; the WeighScore is our editorial judgment per the methodology. Prices change — confirm on each provider's site. Not medical advice; see our disclosure.

← Back to the scorecard